Pharma Fusion and Santa Rosa Merger
Wednesday, 01 April 2026 08:00 AM
Pharma Fusion and Santa Rosa Pharmacy Forge Strategic Merger,
Creating a Next-Generation National Specialty Pharmacy Platform
Expanding high-touch care for patients with bleeding disorders,
immunoglobulin therapies, and hereditary angioedema
LAKE CHARLES, LA / ACCESS Newswire
<https://www.accessnewswire.com/> / April 1, 2026 / Pharma
Fusion announced today, it has entered into a Strategic Merger
Agreement with Santa Rosa Pharmacy, uniting two specialty
pharmacy leaders under a single, patient-centered platform.
The combined integration creates a scaled, national specialty
pharmacy with deep clinical expertise in bleeding disorders,
immunoglobulin (Ig) therapies, and hereditary angioedema (HAE),
designed to deliver high-touch care for patients living with
complex and rare disorders with expensive biological therapies.
The integration amplifies a shared mission: providing deeply
personalized specialty pharmacy services for patients requiring
advanced therapies. By bringing together complementary clinical
strengths, operational infrastructure, and patient centric care
models, the unified Pharma Fusion organization significantly
enhances its ability to support patients, healthcare providers,
and partners across the United States.
Combined, the new Pharma Fusion is projected to generate revenues
of more than $130 million in 2026, positioning the company as a
fast-growing, innovation focused player in the specialty pharmacy
space.
National Reach and Clinical Scale
A core driver of the merger is the powerful, expanded geographic
reach created through the integration of both organizations.
Together, the combined entity will operate with licensing
coverage across 49 U.S. states and three U.S. territories,
including Puerto Rico, Guam, and Saipan, with active plans
underway to secure licensure in the 50th state and additional
U.S. territories, such as the U.S. Virgin Islands.
This expanded national footprint helps remove geographic barriers
that too often limit access to specialty care, ensuring that
patients with rare and complex diseases can receive consistent,
expert clinical support regardless of where they live. For
patients and partners, the new Pharma Fusion represents a single,
unified platform capable of delivering high-touch specialty
pharmacy care at true national scale.
Leadership Alignment and Continuity
In Pharm Fusion the fusion of the merger reflects strong
alignment between the leadership teams and ensures continuity for
patients, providers, and healthcare partners.
Dr. Sajal Roy, formerly Chief Executive Officer of Pharma Fusion,
will transition to Chairman of the Board, focusing on long-term
strategic initiatives and organizational growth.
Dr. Rick Rodrigue will serve as Chief Executive Officer of the
combined Pharma Fusion organization, leading continued growth,
innovation, and operational excellence.
Nicholas Self will continue as Chief Operations Officer,
overseeing operational integration and the development of
specialized disease-state programs.
Caitlin Henderson will continue serving as Chief Administrative
Officer, driving administrative alignment and scalable enterprise
support.
Guillermo Campillo will serve as Chief Experience Officer,
strengthening the organization’s commitment to high-touch
specialty care and an exceptional patient and provider
experience.
“This integration represents a natural evolution for both
organizations,” said Dr. Rick Rodrigue, Chief Executive Officer
of Pharma Fusion. “By aligning our teams and resources, we are
expanding our ability to support patients with complex conditions
across nearly the entire United States, while preserving the
personalized care both organizations are known for and deploying
our AI initiative, Specialty Intelligence(tm).”
Strategic Vision and Specialty Intelligence(tm)
At the center of the combined company’s strategy is Pharma
Fusion’s Specialty Intelligence(tm) approach, which integrates
clinical expertise, proactive care coordination, and personalized
patient engagement to help improve outcomes for patients
requiring complex specialty therapies. This includes a
proprietary AI system that reviews patient health score
statistics and generates insights that are highly relevant to
insurance companies, PBMs, physicians, hospital systems,
pharmaceutical manufacturers, and Medicare.
By analyzing prescribing habits in the rare disease space and
identifying the most cost effective strategies and not limited to
drug cost alone the Specialty Intelligence(tm) platform helps
stakeholders make smarter, data-driven decisions. The result is a
more efficient, more transparent, and more sustainable specialty
care ecosystem that protects both patient outcomes and healthcare
resources.
There will be no disruption to patient care as a result of the
integration. Patients, providers, and healthcare partners will
continue working with the same experienced clinical and
operational teams they trust today, now backed by a larger, more
capable national infrastructure, that is trusted in the industry.
About Pharma Fusion
Pharma Fusion is a specialty pharmacy organization dedicated to
improving health outcomes for patients living with rare and
complex conditions, with locations in Lake Charles, LA and
Bullhead City, AZ. Through its Specialty Intelligence(tm)
approach, the organization integrates clinical expertise,
proactive care coordination, and personalized patient engagement
to support individuals navigating specialty therapies across the
United States.
About Santa Rosa Pharmacy
Santa Rosa Pharmacy, based in Santa Rosa Beach, FL, is a clinical
specialty pharmacy known for its personalized patient care and
expertise in managing complex therapies. The pharmacy supports
patients and healthcare providers nationwide through high-touch
specialty pharmacy services.
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
